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Abstract
Bipolar disorder (BPD) is a debilitating heritable psychiatric disorder. Contemporary rodent models for the manic pole of
BPD have primarily utilized either single locus transgenics or treatment with psychostimulants. Our lab recently
characterized a mouse strain termed Madison (MSN) that naturally displays a manic phenotype, exhibiting elevated
locomotor activity, increased sexual behavior, and higher forced swimming relative to control strains. Lithium chloride and
olanzapine treatments attenuate this phenotype. In this study, we replicated our locomotor activity experiment, showing
that MSN mice display generationally-stable mania relative to their outbred ancestral strain, hsd:ICR (ICR). We then
performed a gene expression microarray experiment to compare hippocampus of MSN and ICR mice. We found
dysregulation of multiple transcripts whose human orthologs are associated with BPD and other psychiatric disorders
including schizophrenia and ADHD, including: Epor, Smarca4, Cmklr1, Cat, Tac1, Npsr1, Fhit, and P2rx7. RT-qPCR confirmed
dysregulation for all of seven transcripts tested. Using a novel genome enrichment algorithm, we found enrichment in
genome regions homologous to human loci implicated in BPD in replicated linkage studies including homologs of human
cytobands 1p36, 3p14, 3q29, 6p21–22, 12q24, 16q24, and 17q25. Using a functional network analysis, we found
dysregulation of a gene system related to chromatin packaging, a result convergent with recent human findings on BPD.
Our findings suggest that MSN mice represent a polygenic model for the manic pole of BPD showing much of the genetic
systems complexity of the corresponding human disorder. Further, the high degree of convergence between our findings
and the human literature on BPD brings up novel questions about evolution by analogy in mammalian genomes.
Citation: Saul MC, Gessay GM, Gammie SC (2012) A New Mouse Model for Mania Shares Genetic Correlates with Human Bipolar Disorder. PLoS ONE 7(6): e38128.
doi:10.1371/journal.pone.0038128
Editor: James Bennett Potash, University of Iowa Hospitals & Clinics, United States of America
Received March 13, 2012; Accepted May 4, 2012; Published June 4, 2012
Copyright:  2012 Saul et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported primarily by a University of Wisconsin–Madison Vilas Associate’s Award to SCG. Additional funding was provided by a National
Institutes of Health R01 to SCG (MH0856427). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: csaul@wisc.edu
Introduction
Bipolar disorder (BPD) is a psychiatric disorder characterized by
episodic mania and depression [1]. It is a common mental health
problem, with an estimated lifetime prevalence of approximately
1–5% [2,3]. A meta-analysis of family, twin, and adoption studies
found that relatives of BPD patients have a 10-fold higher risk of
the disorder than those without relatives with BPD [4], demon-
strating that BPD has a strong heritable constituent. Though
ongoing efforts to elucidate the genetic basis of BPD using varied
approaches have yielded promising results, a convincing molecular
etiology of BPD remains elusive [5]. There are at least a few good
reasons for this difficulty in finding a genetic basis for BPD. First,
BPD is a complex disorder at the molecular level, involving
perturbations of not just single genes, but of systems of genes [6].
Second, it may be more proper to speak of bipolar disorders in the
plural; the pathology may have multiple heterogeneous molecular
bases [6,7], a hypothesis consistent with the multiple heteroge-
neous findings in different genome-wide studies of BPD [8]. Third,
deriving mechanistic explanations of human psychiatric disorders
using classical genetics presents difficulties due to practical
constraints on experimental power and the possibility of epigenetic
components of these disorders [5,9–11].
Because a convincing BPD molecular etiology poses significant
technical and theoretical challenges to human geneticists, animal
models for BPD have a strong potential to extend understanding of
this disorder. The main animal modeling approach to date has
been the use of separate rodent models for mania and depression
[12]. Models for the manic pole of BPD have primarily utilized
treatment with psychostimulants [13,14] or single locus transgenic
approaches like dopamine transporter knockouts [15,16] and
various molecular clock gene knockouts [17,18], though the Black
Swiss strain has recently been proposed as a tentative naturally-
occurring mania model [19,20]. Importantly, there exists at least
one strain of rodent, the Flinders Sensitive Line (FSL) of rat, which
shows a well-validated depressed phenotype relative to control
strains [21]. This strain of rat has been used in multiple studies to
examine several molecular aspects of depression [22–24], and it
has been useful in conceptualizing depression as a disorder with
a complex molecular etiology [12,25].
Our lab recently characterized a tentative model for the manic
pole of BPD [26]. This model, an inbred mouse strain termed
Madison (MSN), displays a naturally manic phenotype. Relative to
control strains, MSN mice show increased locomotor activity,
increased forced swimming, decreased sleeping, and increased
sexual activity. Further, treatments with both lithium chloride and
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condition for a predictively valid model for the manic pole of BPD
[27].
Our initial behavioral and pharmacological characterization of
the MSN strain showed promise, but without molecular correlates,
the model lacked construct validity. Consequently, we performed
a gene expression microarray study with RT-qPCR confirmation
to extend the phenotype of the MSN mouse relative to their
ancestral outbred hsd:ICR (ICR) strain. When choosing which
brain region to interrogate, we decided to look at gene expression
in hippocampus. In humans, hippocampus shows microstructural
and functional differences in BPD patients as assayed by MRI
[28,29]. Further, post-mortem analyses of hippocampal tissue
from BPD patients show multiple histological and gene expression
differences relative to hippocampus from psychiatrically normal
controls [29–32]. Prior to the microarray experiment, we decided
to replicate the most robust measure from our previous behavioral
work, total locomotor activity, to confirm that MSN mice stably
display a manic phenotype.
Results
Total Locomotor Activity
Locomotor activity defined by total distance traveled (Fig. 1.A)
was significantly higher in MSN mice than in ICR mice (P-
value=7610
27, Monte Carlo permutation test,
nMSN=n ICR=19, Z=24.24, B=1610
7). The probability density
distribution for total distance travelled for MSN mice was bimodal
whereas the probability density distribution for ICR mice was
unimodal (Fig. 1.B). Since the MSN strain is almost completely
inbred, we do not believe this bimodality is evidence of two
separate populations within the MSN strain.
Single Gene Microarray Results
The hundred best annotated genes with the most significant P-
values along with a heatmap showing expression in each of the
tested samples are listed in Fig. 2. MSN mice showed significant
differences in gene expression in multiple genes whose orthologs
are associated with BPD and the related mental health disorders
schizophrenia, depression, and ADHD in the human literature.
Significantly-dysregulated genes (P-value ,1610
23) whose human
orthologs have been associated with these disorders in at least two
separate studies include: Cp (P-value=1.25610
25,t = 27.421)
[33–35], Epor (P-value=2.73610
25, t=6.823) [36–38], Pdgfra
(P-value=4.38610
25, t=6.476) [39,40], Tac1 (P-val-
ue=9.03610
26,t = 27.684) [41–43], P2r67 (P-val-
ue=6.72610
25,t=26.170) [44–49], Fhit (P-value=5.20610
25,
t=26.352) [50,51], and Cat (P-value=6.56610
26, t=7.946)
[52,53]. Significantly-dysregulated genes whose human orthologs
have been associated with BPD or a related mental health disorder
in one study include: Smarca4 (P-value=7.58610
27,t=29.897)
[54], Mut (P-value=3.44610
26,t = 28.495) [55], Git1 (P-
value=6.24610
26, t=7.988) [56], and Cmklr1 (P-val-
ue=1.12610
24, t=5.818) [57]. An additional dysregulated gene
of interest we identified whose human ortholog has not been
associated with BPD or related mental health disorders as far as we
know is Npsr1 (P-value=9.48610
24, t=4.455). This gene’s
product is a G-protein coupled receptor generally involved with
arousal and activity [58,59]. The names of genes discussed here
are highlighted in light orange in Fig. 2. All reported values use an
empirical Bayesian t-test with 10 degrees of freedom.
RT-qPCR Confirmation of Microarray Results
We confirmed the results of seven genes from our microarray
experimentsusingRT-qPCR.Wechosegenesforconfirmationwith
anemphasisongeneproductsthatwethoughtwereeitherrelatedto
neural signaling pathways it would be possible to target pharmaco-
logically or genes we could use as dependent variables in the future.
WetestedCat(P-value=0.001,expressionratio=1.202),Cmklr1(P-
value,0.001, expression ratio=1.404), Epor (P-value,0.001,
expression ratio=1.370), Fhit (P-value,0.001, expression ra-
tio=0.446), Npsr1 (P-value=0.021, expression ratio=2.426),
P2rx7 (P-value=0.006, expression ratio=0.681), and Tac1 (P-
value=0.001,expressionratio=0.696).TheresultsoftheRT-qPCR
confirmationareshowninFig.3.Allsevengeneswechosetoconfirm
werefoundsignificantlydysregulatedinthesamedirectionandatthe
same approximate magnitude as in the results of the microarray
experiment. Altogether, our RT-qPCR confirmation provides
evidence that our microarray data arefundamentally sound.
Genome Enrichment Analysis
NIAID DAVID functional annotation analysis by cytoband of
all genes dysregulated at P,0.01 found a significant enrichment in
murine cytoband 5qF (3.789-fold enrichment, Bonferroni-cor-
rected P-value=7.84610
27) in MSN mice. We found this result
intriguing, but we believed this cytoband-style enrichment analysis
utilized genome regions too wide to allow the assumption of
classical genetic linkage. We created a new algorithm for genome
enrichment analysis with much narrower partitions of the genome
queried. Our novel genome enrichment analysis yields results that
look very similar to a conventional genome-wide linkage or
association study, and we find it useful for generating predictions
for broad chromosomal regions potentially related to a given
population’s phenotype. We found significant enrichment in a total
of fifteen genome regions (Fig. 4.A).
When looking at the significantly enriched genome regions, we
decided to examine their relationship to the human genome, so we
qualitatively looked at shared synteny, a similar clustering of
orthologous genes between species that generally demarcates
genome homology. We looked for linkage and association
literature implicating the enriched regions’ human homologs in
BPD and related mental health disorders like schizophrenia and
Figure 1. Confirmation of the MSN manic phenotype using an
experimental replication of the most robust behavioral
measure from previous research on this mouse strain, total
locomotor activity. A) MSN mice display stable heightened
locomotor activity relative the outbred strain. ***P,0.001. B) The
probability density for MSN mouse total locomotor activity is bimodal,
while the probability density for the control strain is unimodal. This
leads us to the hypothesis that MSN mice may display behavioral
bipolarism, a hypothesis that will be examined in future work.
doi:10.1371/journal.pone.0038128.g001
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in at least two linkage studies with at least one study showing
a LOD or NPL score (linkage score) greater than 3 as a region with
a strong relationship to BPD. Using this criterion, we found that
eight of the enriched genome regions in MSN mice are
homologous to seven human genome regions displaying strong
relationships to BPD. Shared synteny for these regions is shown in
Fig. 4.B. These regions include the following cytobands: murine
4qE, homologous to human 1p36, implicated in BPD in two
studies with linkage scores of 3.97 [60] and 3.1 [61] and a region
in which SNPs predict BPD susceptibility [62]; murine 5qF,
homologous to human 12q24, implicated in BPD in multiple
studies with linkage scores of 4.91 [63], 3.63 [64], 3.37 [65], 2.8
[61], and 2.08 [66] and a region in which SNPs and allele variants
predict BPD susceptibility [44,46,67]; 8qE1, homologous to
human 16q24, implicated in BPD in two studies with linkage
scores of 3.51 [68] and 2.29 [69]; murine 11qE2, homologous to
human 17q25, implicated in BPD in five studies with linkage
scores of 3.11 [70], 2.4 [71], 2.4 [72], 2.1 [73], and 2.08 [74];
murine 13qA3 and 17qA3-17qB1, two cytobands with homology
to human 6p21–22, implicated in BPD in multiple studies with
linkage scores of 3.19 [68], 2.60 [75], 2.26 [72], and 1.91 [69];
murine 14qA1, homologous to human 3p14, implicated in BPD in
two studies with linkage scores of 3.51 [76] and 2.31 [77]; and
Figure 2. Heatmap of normalized values for the top 100 well-annotated genes from the microarray experiment listed by P-value in
order from top to bottom, then left to right. The lowest P-values are at the top left corner, and the highest are at the bottom right. Blue values
represent lower expression and orange values represent higher expression. The names of the genes discussed in the text of this manuscript are
highlighted in light orange.
doi:10.1371/journal.pone.0038128.g002
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BPD in two studies with linkage scores of 3.74 [78] and 2.0 [61].
Additional enriched genome regions showing weaker previous
relationships to BPD included: murine 2qE, homologous to
human 11p13, implicated in BPD in one study with a linkage
score of 1.95 [79] and a region in which SNPs and allele variants
predict BPD susceptibility [80,81]; murine 8qB2–B3.1, homolo-
gous to human 4q34, implicated in BPD in a study with a linkage
score of 3.28 [82]; murine 8qB3.3 and 9qA3, homologous to
human 19p13, implicated in BPD in three studies with linkage
scores of 2.37 [83], 1.8 [66], and 1.55 [84]; and 15qE3,
homologous to 22q13, implicated in BPD in one study with
a linkage score of 2.22 [85]. One cluster at murine cytoband
13qD1 shared synteny with human 5q13–14, a region with no
significant linkage to BPD in any human literature we could find,
but implicated in schizophrenia in a study with a linkage score of
3.20 [86] and implicated in ADHD in a study with a linkage score
of 4.16 [87]. A cluster on the X chromosome consisted of mostly
predicted genes with no obvious orthology to known human genes.
We were not able to find shared synteny between this region and
any human region.
Functional Network Analysis
NIAID DAVID analysis of all genes with FDR-adjusted P-
values less than 0.25 found a significant gene cluster generally
related to chromatin packaging, so we decided to pursue this
finding using Cytoscape to visualize this cluster. Using a gene list
generated from this DAVID analysis, we found a network of genes
generally related to chromatin packaging that was significantly
dysregulated in our microarray study. These genes included a few
histone-related genes as well as Smarca4, a gene we found to be
one of the most highly-dysregulated in the microarray results that
has helicase and chromatin remodeling activities. The chromatin
packaging gene network is shown in Fig. 5, with nodes in orange
representing those genes found dysregulated in our microarray
results and nodes in blue representing linking genes previously
found related to chromatin packaging not significantly dysregu-
lated in our microarray. These results suggest that differential
chromatin packaging is part of the MSN phenotype, which is
convergent with the findings of a recent systems biology meta-
analysis of BPD [54].
Discussion
A Complex Phenotype
As BPD is a genetic disorder involving systems of genes [6,8,54],
models for either pole of BPD representing single genes, while
valuable for many purposes, are necessarily limited. A mammalian
genome containing upwards of 30,000 genes is a complex system,
and while understanding the effects of single genes and their
products will always be necessary, their results should be
understood in a systems biology context. We believe that the
MSN strain represents among the first true systems biology models
for the manic pole of BPD characterized. The polygenic nature of
this model presents both challenges and promise. The quantity of
loci involved in the phenotype makes inference difficult relative to
single locus models, but it reproduces the physiology of the
disorder more completely and more subtly. We believe the MSN
mouse strain will enable us to glean new insights into the biology of
BPD based upon not only face validity, but on fundamental
biological construct validity.
The basis of this polygenic phenotype is the MSN strain’s ,15
year history of multifaceted inbreeding. The ancestral strain of
these mice was one of four replicate strains originally bred for high
wheel running in a study on exercise physiology [88]. The
ancestors showed few notable exercise physiological changes; the
most significant changes observed in this strain displayed were
neurological [89]. These MSN ancestors were part of a 2003
hippocampus microarray paper comparing selectively bred strains
with control strains [90]. None of the 53 genes found significantly
dysregulated in the 2003 microarray experiment overlap with the
significantly dysregulated genes from the present study, and most
of these 53 genes are quite far from significance in the current
array. While methodological differences prevent easy comparisons
between the 2003 microarray and the current microarray, we
believe the fundamental divergence of the two arrays implies that
the chief physiological changes we see in the MSN strain likely
emerged after the MSN progenitors were selectively-bred for high
wheel running. The sole selection event occurring after the
original microarray experiment was ,30 generations of selection
to maintain a trait already observed in the MSN progenitors, high
maternal defense [91]. After this maintenance selection, the MSN
strain’s ancestors were maintained in our lab without selective
breeding. Given the lack of breeding toward a novel phenotype,
we believe many of the important genetic changes contributing to
the MSN phenotype are likely attributable to genetic drift. This is
not to deemphasize the effect of the original selective breeding for
high wheel running, which provided the genetic foundation of the
MSN strain. We suggest that the MSN strain’s manic phenotype
emerged through a series of random events acting upon an already
constrained gene pool.
The MSN mouse strain’s locomotor activity displays a bimodal
distribution while the outbred mouse strain’s locomotor activity
shows a unimodal distribution. Because the MSN strain is highly
inbred, we believe this bimodality does not suggest divergent
populations of mice within the MSN strain. Instead, we speculate
that the MSN strain may show a phenotype with true behavioral
cyclicity, a finding that has never been seen in a rodent model as
far as we know. We are currently working on a behavioral project
to examine this possibility in greater detail.
Implications of the Genome Findings
The genome enrichment algorithm we developed is a new and
useful method extending the suite of systems biology tools for high-
throughput gene expression data. This algorithm can be applied to
gene expression datasets old and new to enhance the biological
understanding of the genome as a substrate for the organization of
gene systems. Importantly, we believe it predicts both potential
perturbations of the genome and of the epigenome, which would
provide a more complete accounting of the mechanistic under-
pinnings of differences on the genome than classical genetics can.
Figure 3. RT-qPCR confirmation results for seven genes from
the microarray. Ratio distribution is graphed as a box-and-whiskers
plot. Ratios greater than 1 represent genes with higher expression in
the MSN strain and ratios less than 1 represent genes with lower
expression in the MSN strain relative to the ICR strain. *P,0.05;
**P,0.01; ***P,0.001.
doi:10.1371/journal.pone.0038128.g003
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this technique has the potential to inform biologists not only about
where to look for differences on the genome, but for which types of
differences they should interrogate each genome regions.
While this genome enrichment analysis does not substitute for
a true genome-wide linkage scan, we believe it provides a strong
prediction that the MSN genome experiences perturbations in
areas homologous to human genome regions linked to BPD in
some populations. Why human populations with BPD should
show differences in the genome relative to psychiatrically normal
comparisons is an interesting question. Why MSN mice might
share some of the same genomic perturbations as some human
BPD populations is a compelling extension of this question. We
propose that because the structural and functional components of
Figure 4. Genome enrichment analysis and homology of highlighted enriched clusters to the human genome. A) Genome enrichment
analysis of the MSN phenotype using a novel enrichment algorithm we created for this study (see Materials and Methods). The y-axis represents the
log10 inverse of the corrected binomial probability that a cluster of dysregulated genes would occur by chance. The black horizontal lines demarcate
a cluster occurring by chance with a 0.001 corrected probability, consistent with a LOD or NPL score of 3 in a linkage study. Spikes above the black
lines indicate dysregulated gene clusters highly unlikely to occur by chance, indicating that the genome region is significantly enriched. Corrected
probabilities less than 1610
29 are collapsed to 1610
29. B) Shared synteny, a similar clustering of orthologous genes, between the clusters on the
murine genome highlighted in orange in Fig. 4.A and human genome regions strongly implicated in BPD (see Results for details). Blue lines represent
orthologous genes and their positions in the murine (upper) and human (lower) genomes.
doi:10.1371/journal.pone.0038128.g004
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given analogous evolutionary events, display analogous changes.
Put more simply, similar genomes experiencing similar forces react
similarly. In this case, we believe we may have found a conserved
genomic signature observable even after the some 75 million years
since the divergence of the mouse and human lineages [92]. We
speculate that this signature is related generally to neural
activation and organismal arousal. Further, our findings suggest
that conserved genomic signatures may exist for other disorders
and traits.
Conclusions
Though these results show promise, we must include caveats
based upon the complex nature of the phenotype and the
limitations of the techniques we used. MSN mice weigh
significantly less than ICR controls (t27.957=23.986, P-val-
ue=4.369610
24, Welch’s two-sample t-test), which shows that
the MSN background includes other characteristics potentially
unrelated to mania. While the microarray platform we used was
designed to be robust against the effects of polymorphisms in the
probes, ultimately, we cannot preclude the possibility of coding
changes in the probe binding sites of some genes of interest
affecting our results. Similarly, while we made all practical efforts
to design qPCR oligonucleotides on monomorphic sites, we
cannot say with certainty that our primer binding sites do not
contain novel polymorphisms. Additionally, as we noted in the
results, some of the evidence from the human literature we
utilized to contextualize our results is unreplicated.
Despite these complexities, when we look at the rich suite of
systems biology differences present in MSN strain relative to the
closely related ICR strain, we believe we have found a strong
phenotype that models mania with high construct validity. We
Figure 5. Network analysis of a dysregulated gene network related generally to chromatin packaging. The diamond-shaped orange
nodes indicate genes found significantly dysregulated MSN mice while the circular blue nodes indicate related genes called by the MiMI plugin for
Cytoscape. A recent systems meta-analysis of human BPD genome and transcriptome studies found that a significant chromatin packaging effect is
seen across multiple human BPD populations [54].
doi:10.1371/journal.pone.0038128.g005
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of work done on human BPD genetics using three levels of
analysis. At the single gene level, MSN mice display dysregulation
of multiple transcripts whose human orthologs are related to BPD
and related mental health disorders [8,33–57]. At the systems
level, MSN mice display dysregulation of a gene network similar to
one found conserved across multiple human studies on BPD in
a recent systems meta-analysis [54]. At the chromosomal level,
MSN mice display perturbations in eight murine genome regions
homologous to seven human genome regions with strong relation-
ships to BPD in the human literature [60–78]. We believe that the
argument for analogy between MSN mice and human BPD is
strong. The genetic, systems, and genome findings we present here
imply profound physiological similarities.
Just as the etiology of human BPD remains unresolved [5], so
do the mechanistic underpinnings of the MSN strain’s
phenotype. This study is an extension of our effort to
characterize the phenotype and a preliminary step in the
process of finding a genotype. While we believe we have fully
utilized a strong dataset to glean an interesting picture of these
mice, until we understand more about the genomics behind the
MSN phenotype, the scope of our work remains limited. We
believe the loci from our novel genome enrichment analysis give
us a set of targets relevant to a potential deep sequencing
project. Comparing the MSN genome with the outbred ICR
genome will be an important next step and will contribute
much to our understanding of BPD.
Materials and Methods
Ethics Statement
Animal use was carried out in accordance with the recommen-
dations in the Guide for the Care and Use of Laboratory Animals
of the National Institutes of Health. All protocols were approved
by the University of Wisconsin–Madison IACUC (protocol #:
L00405-0-05-09), and all reasonable efforts were made to
minimize animal suffering.
Animals
MSN is an inbred strain of mouse derived over the course of
approximately 15 years from the outbred hsd:ICR (ICR) mouse
strain (Harlan Laboratories, Madison, WI, USA), making the ICR
strain a natural control. The ancestors of MSN mice were one of
four replicate strains selected over a period of ,30 generations for
high wheel running behavior [88]. This high wheel running
ancestral strain was observed to display high maternal defense
behavior compared to both control lines and the other three lines
selected for high wheel running from the original selective
breeding experiment [91]. The ancestral mice were then bred
for an additional ,30 generations to maintain high maternal
defense behavior. This progenitor strain was also characterized as
showing maternal neglect [93]. The mice were maintained in
a breeding colony in our lab without selection for multiple
generations, likely experiencing genetic drift and fixation before
our lab eventually observed them to display a manic phenotype
relative to control strains [26]. The MSN strain is now highly
inbred; we estimate its current inbreeding coefficient at 0.95. The
MSN and ICR strains were kept in separate breeding colonies in
our laboratory under similar conditions for multiple generations
prior to this study. Mice from this study were adult males from the
same generation singly housed in the same room, and all mice
were approximately 10 weeks old during testing.
In-cage Locomotor Activity Observations
Total in-cage locomotor activity observations during portions of
both the light and dark periods were made using a camera
mounted above mouse home cages with online analysis done by
the TopScan 2.0 software (CleverSys, Reston, VA, USA) as
described previously [26], though for this experiment, we observed
MSN mice during one day and not two. In total, 19 MSN mice
and 19 ICR mice were observed. Statistical inference for total
distance traveled over time tested was done using the Monte Carlo
permutation test implementation in the R package coin. Proba-
bility density plots were made using the R package sm, a non-
parametric smoothing algorithm for histograms.
Tissue Collection
The day after observation of total locomotor activity, mice were
weighed, anesthetized with isofluorane gas, and decapitated. After
whole brains were removed, hippocampal tissue was quickly
dissected out and the hippocampi were flash-frozen over dry ice.
Hippocampal tissue was kept frozen at 280uC for no longer than
12 weeks prior to use in downstream molecular biology
applications. Statistical inference on animal weight was performed
using the t.test function in R.
RNA Extraction
Total RNA was extracted using an Aurum Total RNA Fatty
and Fibrous Tissue Kit (Bio-Rad, Hercules, CA, USA) to
manufacturer specifications. Briefly, tissue was disrupted in a low
pH phenol-chloroform-guanidium thiocyanate solution and spun
down. The aqueous phase was combined with ethanol and passed
through a spin column to bind RNA. The RNA was cleaned and
DNase treated on-column, purified total RNA was eluted in
nuclease-free elution buffer, and samples were frozen at 280uC
prior to use in downstream applications.
Microarray Target Preparation, Hybridization, and
Scanning
Using the true random number generation service random.org,
6 mice from the MSN group and 6 mice from the ICR group were
chosen at random from the mice used in behavioral observations.
Prior to the microarray experiment, all total RNA samples were
checked for purity, integrity, and concentration using a NanoDrop
ND-1000 spectrophotometer (Thermo Fisher, Waltham, MA,
USA) in concert with RNA 6000 Pico Chips in a 2100
BioAnalyzer (Agilent Technologies, Santa Clara, CA, USA). The
microarray experiment utilized the GeneChip Mouse Gene
1.0 ST platform (Affymetrix, Santa Clara, CA, USA), a platform
with probesets consisting approximately 27 probes spaced along
the length of each gene interrogated to minimize the effects of
polymorphic sites on the expression results for the gene as a whole,
with biotinylated targets derived from total RNA. Briefly, cDNA
for hybridization was synthesized from 400 ng of total RNA using
a GeneChip WT Expression Kit (Ambion, Austin, TX, USA)
according to the manufacturer’s specifications. The cDNA was
fragmented, then biotinylated using a WT Terminal Labeling Kit
(Affymetrix, Santa Clara, CA, USA) according to the manufac-
turer’s specifications. Biotin-labeled cDNA was hybridized with
microarrays at 45uC for 16 hours. The hybridized arrays were
washed, stained, and scanned on a GC3000 G7 Scanner
(Affymetrix, Austin, TX, USA). Data were extracted and
processed from the scanner using the Affymetrix Command
Console software, v. 3.1.1.1229. Microarray target preparation,
hybridization, and scanning were performed by the Gene
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Wisconsin–Madison.
Probeset Level Normalization, Summarization, and
Statistical Inference
Probeset-level normalization and summarization were per-
formed with the PLIER algorithm with GC-bin background
correction using the Affymetrix Power Tools software, v. 1.12.0
and revision 4 of the Affymetrix library for the Mouse Gene
1.0 ST version 1 array platform. The raw and summarized
microarray data discussed in this publication have been deposited
in the NCBI’s Gene Expression Omnibus [94] and are available
through the GEO website, accession number GSE29417. In-
ferential statistics for differential expression between MSN and
ICR samples were calculated using the microarray-specific
empirical Bayesian t-test implementation in the Bioconductor
package limma, v. 3.6.9 [95], to calculate nominal P-values and
Microsoft Excel 2010 to calculate linear fold-change differences. A
tab-delimited spreadsheet containing exhaustive microarray sta-
tistical results with annotations from both Affymetrix, a reliable
annotation source, and fill-ins for transcript clusters unannotated
by Affymetrix from Ensembl’s BioMart, a less reliable annotation
source, is posted as supplementary Table S1.
RT-qPCR Validation of Microarray Results
We have included an RT-qPCR supplement, Table S2, which
contains all of the information about the RT-qPCR methods from
this study required by the MIQE [96].
A total of 8 MSN mice and 8 ICR mice were selected for RT-
qPCR confirmation. An additional 2 MSN mice and 2 ICR mice
were selected using random.org from the same set of mice for RT-
qPCR confirmation to add to the 6 MSN and 6 ICR mice used in
the microarray experiment. RNA extraction from hippocampi of
the additional animals was done at the same time as extraction for
the animals used in the microarray experiment. Fresh aliquots of
RNA were used for RT-qPCR confirmation to avoid samples
differentially exposed to freeze-thaw cycles. Prior to RT-qPCR
confirmation, total RNA was checked for purity, integrity, and
concentration using both a NanoDrop ND-1000 spectrophotom-
eter and RNA 6000 Nano Chips in an Agilent 2100 BioAnalyzer.
Results of quality control are reported in table S2.10.
Seven gene transcripts found significantly dysregulated in the
microarray were chosen for validation by RT-qPCR: catalase
(Cat); chemokine-like receptor 1 (Cmklr1); erythropoietin receptor
(Epor); fragile histidine triad (Fhit); neuropeptide S receptor 1
(Npsr1); purinergic 26 receptor 7 (P2rx7); and tachykinin,
precursor 1 (Tac1). As they were recently demonstrated among
the most stable gene transcripts of the widely used RT-qPCR
reference genes in the rodent brain [97,98], the transcripts for
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activa-
tion protein, zeta polypeptide (Ywhaz) and succinate dehydroge-
nase complex, subunit A, flavoprotein (Sdha) were chosen as
reference genes for this study. Primers for all transcripts were
designed in NCBI’s online Primer-BLAST software suite set to use
strict in silico specificity requirements and to preclude primer
binding sites on known polymorphic sites. Primer sequences are
reported in table S2.11.
We used a two-step protocol for RT-qPCR. Reverse transcrip-
tion was done using a SuperScript III First-Strand Synthesis
System for RT-PCR (Invitrogen, Carlsbad, CA, USA) according
to the manufacturer’s specifications. 2 mg of total RNA were used
as template for each sample, a poly-T 20 mer priming strategy was
used, and reaction volumes were scaled up to 26.25 mL. Reverse
transcription reactions were done in a MasterCycler Personal PCR
Machine (Eppendorf, Hamburg, Germany). The resultant cDNA
was diluted 1:5 with nuclease-free water to minimize the effects of
any PCR inhibitors. The specifics of cDNA synthesis are listed in
table S2.4.
Real-time quantitative PCR was done in a StepOnePlus real-
time thermal cycler (Applied Biosystems, Foster City, CA, USA)
using SsoFast EvaGreen Supermix (Bio-Rad, Hercules, CA, USA)
according to manufacturer recommendations. Total reaction
volumes of 20 mL were used; each reaction contained 10 mLo f
26Supermix, 2 mL diluted template cDNA, 500 nM forward and
reverse primers, and nuclease-free water up to the final reaction
volume. All reactions were performed in triplicate. We utilized
a three-step thermal cycling protocol that included a 30 s hot start
at 95uC, then 40 cycles of a denaturation step at 95uC for 5 s, an
annealing step at a temperature empirically-determined for each
primer set for 20 s, and an elongation step at 72uC for 20 s.
Annealing temperatures for each primer set are available in table
S2.4. Fluorescence data were collected at the annealing step of
each cycle. All experimental qPCR runs were accompanied by
a dilution series to calibrate PCRs for empirical efficiency and by
a dissociation curve to determine in vitro primer specificity. All
consumables are listed in table S2.7.
Cq values were determined using the StepOnePlus software, v.
2.1, with the same fluorescence threshold for every qPCR run.
Descriptive and inferential statistics were calculated using the
Relative Expression Software Tool (REST), v. 2009, which
corrects for empirical PCR efficiency, allows for the use of
multiple reference genes, and utilizes a Monte Carlo style
permutation test for significance [99]. We set the REST software
to perform 10,000 iterations for the permutation test, and we also
used it to find expression ratio of MSN:ICR.
Genome Enrichment Analysis and Shared Synteny
Analysis
To map genome regions with significant enrichment, we built
a novel enrichment algorithm that looks at clustering of
dysregulated genes along the length of a chromosome. This
algorithm works by walking along the length of a chromosome at
1.25 Mb intervals, a distance corresponding to a little less than 2.5
centimorgans in mice. The algorithm bins all genes assayed in our
microarray platform within 1.25 Mb of the center of each interval
and counts them. The bins are staggered to prevent bias against
clustering at bin breakpoints. The algorithm counts all genes
dysregulated at a nominal P-value of 0.01 or less. The amount of
genes significantly dysregulated within each interval should, under
a null hypothesis of no significant enrichment of that genome
region, display a binomial distribution with a probability of any
given gene being significantly dysregulated at no more than 0.01.
Our algorithm calculates the binomial probability of the amount
of the amount of dysregulated genes within each interval over the
entire genome. The probabilities are Bonferroni-corrected for
multiple comparisons, then the log10 of the inverse of the
probabilities are graphed. A log10(p
21) of 3 indicates a Bonfer-
roni-corrected probability of a cluster occurring 1 in 1,000 times
under the null hypothesis of no significant clustering in any
particular genome region. This corresponds to the LOD score of 3
commonly used as the cutoff criterion for strong evidence of
linkage in linkage scans. Any log10(p
21) value greater than or equal
to 9 is collapsed to 9 for ease of visualization. The resulting graphic
examines clusters over the whole genome, and spikes indicate
clusters highly unlikely to have occurred by chance. The Excel file
used to create this analysis is included as supplementary Table S3.
This method for calculating the probability of a gene cluster
occurring by chance is vulnerable to statistical artifacts introduced
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annotation source looking at gene-level and not exon-level
information. Additionally, it is necessary to systematically curate
any gene-level probeset redundancy out of the annotation source
used. We used release 32 of the Affymetrix annotation for our
array platform, which contains no exon-level information. Further,
we chose the probesets with the lowest P-values to represent their
genes, then deleted all other probesets representing each individual
gene to get rid of any remaining gene-level redundancy. We
manually inspected the data contributing to each significant
finding to confirm that they were not redundant or otherwise
problematic.
Shared synteny analysis utilized the homology map on the
NCBI’s website, which has a map showing homologous genome
regions between humans and mice. Graphics were generated using
the positional information present in the homology map.
Functional Network Analysis
We utilized a network analysis methodology similar to that
used in a recent biological systems meta-analysis done on human
BPD datasets [54]. Using a list of every gene with an FDR-
adjusted P-value less than or equal to 0.25 from the gene-level
microarray inferential statistics, we utilized the functional
annotation clustering tool of NIAID’s DAVID software
[100,101]. We set the functional annotation tool to default
settings with medium stringency and a background matching the
array platform we used. The most significantly enriched cluster
was related to ribosomes. Many of the genes in this cluster were
pseudogenes, so we decided to ignore this cluster for the purposes
of gene network analysis. The second most significant cluster we
found had gene components generally related to chromatin
packaging. We took the genes from this cluster and put them into
the MiMI plugin v. 3.11 [102] in Cytoscape v. 2.8.0, setting the
software to query genes with shared nearest neighbors in order to
get rid of genes not closely related to the chromatin packaging
network. The resulting network was large, with 183 nodes and
6234 edges. To reduce this network to the genes most closely
related to chromatin packaging, we used the Glay plugin v. 2.0
[103] to find subnetworks. We found the subnetwork most closely
related to chromatin remodeling, which is what we report in this
study.
Supporting Information
Table S1 Tab-delimited text file containing exhaustive micro-
array statistical analysis for all transcript clusters organized by P-
value. Annotation sources from build 32 of the Affymetrix
annotation for the Mouse Gene 1.0 ST platform with presumptive
annotation filled in by Ensembl’s BioMart extension.
(TXT)
Table S2 Portable document file containing all information on
RT-qPCR assays considered essential by the MIQE.
(PDF)
Table S3 Excel file containing results from the genome
enrichment analysis broken down by chromosome.
(XLSX)
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